Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.
Genetic Glyco-Engineering/ ADCC (GlymaxX®)
Boost your antibodies’ potency with our GlymaxX ADCC enhancement technology
Genetic Glyco-Engineering/ ADCC (GlymaxX®)
DirectedLuck® Transposase with Epigenetic Targeting
Give your protein a ride on a cellular engine
DirectedLuck® Transposase with Epigenetic Targeting
Productivity Increase
One gene to boost them all – see how you can optimize your titers with our proven Pathway Modulator
Productivity Increase
Viral Vector Technologies
ProBioGen's MVA platform – the most efficient production system for a potent vaccine vector
Viral Vector Technologies
Virus Production Cell Lines
A scalable cell line is the bedrock of industrial production. See what our high-yield lines can do for your virus or vector!
Virus Production Cell Lines
Lenti.RiGHT™ Lentivirus Packaging and Producer Cell Line
Enables a scalable production of high-titer lentiviral particles for gene transfer applications.
Lenti.RiGHT™ Lentivirus Packaging and Producer Cell Line
Quality Management
The high quality of ProBioGen’s products relies on the synergetic improvement of each individual process step. Our quality management system is based on standard DIN EN ISO 9001:2015 and specifically tailored to serve our client's individual requirements. ProBioGen holds a manufacturing authorization for GMP compliant manufacturing and batch release of biotechnological drug substances.
